• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR NC TREK CORONARY DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR NC TREK CORONARY DILATATION CATHETER Back to Search Results
Model Number 1012451-12
Medical Device Problem Codes Difficult to Remove (1528); Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/09/2022
Type of Reportable Event Malfunction
Event or Problem Description
T was reported that the procedure was to treat a 90% stenosed, mildly calcified vessel without tortuosity in the mid right coronary artery (mrca).After a 3.5mm drug eluting stent was deployed in the mrca, there was malapposition at the proximal edge.The 3.5x12mm nc trek balloon dilatation catheter (bdc) was used for post-dilatation.However, the balloon ruptured during the first inflation at 12atm for 10 seconds.Prior to use, the catheter was soaked in saline and was prepared (air aspiration) inside the anatomy.There was no resistance when the protective sheath was removed and there was no resistance during advancement.There was resistance with a guide catheter during removal.A non-abbott balloon was used to complete the procedure.There was no adverse patient effect.There was no reported clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that the procedure was to treat a 90% stenosed, mildly calcified vessel without tortuosity in the mid right coronary artery (mrca).After a 3.5mm drug eluting stent was deployed in the mrca, there was malapposition at the proximal edge.The 3.5x12mm nc trek balloon dilatation catheter (bdc) was used for post-dilatation.However, the balloon ruptured during the first inflation at 12atm for 10 seconds.Prior to use, the catheter was soaked in saline and was prepared (air aspiration) inside the anatomy.There was no resistance when the protective sheath was removed and there was no resistance during advancement.There was resistance with a guide catheter during removal.A non-abbott balloon was used to complete the procedure.There was no adverse patient effect.There was no reported clinically significant delay in the procedure.Subsequent to the initially filed report, the following information was provided: there was resistance with the guide catheter during removal but the nc trek bdc was removed independently.There was no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.The investigation determined the reported complaints appear to be related to operational context.There is no indication of a product quality issue with respects to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC TREK CORONARY DILATATION CATHETER
Common Device Name
CORONARY DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14886425
Report Number2024168-2022-07141
Device Sequence Number5162857
Product Code LOX
UDI-Device Identifier08717648151972
UDI-Public08717648151972
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K103153
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2024
Device Model Number1012451-12
Device Catalogue Number1012451-12
Device Lot Number11215G1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/13/2022
Supplement Date Received by Manufacturer07/08/2022
Initial Report FDA Received Date07/01/2022
Supplement Report FDA Received Date07/26/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/15/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GUIDING CATHETER
Patient SexUnknown
-
-